2-Bromo-6-chloro-1,7-naphthyridine, 95%, 5g

1H-Pyrazole-3,5-dicarboxylic acid, 97.0%, 500g

Methyl 6-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate, 97%, 250mg

6-Iodo-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene, 95%, 1g

2-(5-Bromopyridin-2-yl)propan-2-amine, 95+%, 1g

4,4',4''-((1,3,5-Triazine-2,4,6-triyl)tris(oxy))trianiline, 97%, 250mg

(R)-1-phenylethanamine (2S,3S,4R)-4-(benzo[d][1,3]dioxol-5-yl)-1-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate, 98%, 50mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(((benzyloxy)carbonyl)amino)butanoic acid, 97%, 250mg

2-Amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine>98.0%(GC)(T)5g

Plan Apochromatic 2.0 x objective for the DZ series. Working distance 33 mm. Mounted under a DZ zoom module

(2,6-Dimethylphenyl)(1H-imidazol-4-yl)methanol, 95.0%, 100mg

(R)-2,2'-Bis(di-p-tolylphosphino)-1,1'-binaphthalene, 97%, 250mg

2,2,2-Trifluoroethanol, min. 99.8%, for synthesis, 250 ml, glass packaging